Bacterial cell factories for recombinant protein production; expanding the catalogue

Microbial Cell Factories

Volumn 12, Issue 1, 2013, Pages

  Ferrer Miralles, Neus ^a,b   Villaverde, Antonio ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; RECOMBINANT PROTEIN;

ACTINOBACTERIA; BACTERIAL CELL; BACTERIAL GENETICS; BACTERIAL GROWTH; BACTERIUM CULTURE; BIOSAFETY; COST; DISULFIDE BOND; EDITORIAL; ESCHERICHIA COLI; FIRMICUTES; FOOD CONTROL; GENE EXPRESSION; HOST; LACTIC ACID BACTERIUM; MOSS; MOULD; NONHUMAN; PLASMID; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN SECRETION; PROTEOBACTERIA; PROTOZOON; SACCHAROMYCES CEREVISIAE; STRESS;

BACTERIA (MICROORGANISMS);

BIOTECHNOLOGY; RECOMBINANT PROTEINS;

EID: 84887682647     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-12-113     Document Type: Editorial

References (79)

1. Sorensen HP. Towards universal systems for recombinant gene expression. Microb Cell Fact 2010, 9:27. 10.1186/1475-2859-9-27, 2876075, 20433754.
2. Ferrer-Miralles N, Domingo-Espin J, Corchero JL, Vazquez E, Villaverde A. Microbial factories for recombinant pharmaceuticals. Microb Cell Fact 2009, 8:17. 10.1186/1475-2859-8-17, 2669800, 19317892.
3. Ward OP. Production of recombinant proteins by filamentous fungi. Biotechnol Adv 2012, 30:1119-1139. 10.1016/j.biotechadv.2011.09.012, 21968147.
4. Arya R, Bhattacharya A, Saini KS. Dictyostelium discoideum -a promising expression system for the production of eukaryotic proteins. FASEB J 2008, 22:4055-4066. 10.1096/fj.08-110544, 18714070.
5. Decker EL, Reski R. Moss bioreactors producing improved biopharmaceuticals. Curr Opin Biotechnol 2007, 18:393-398. 10.1016/j.copbio.2007.07.012, 17869503.
6. Potvin G, Zhang Z. Strategies for high-level recombinant protein expression in transgenic microalgae: a review. Biotechnol Adv 2010, 28:910-918.
7. LEXSY Biosafety Status. 2013, http://www.jenabioscience.com/cms/en/1/browse/1879_biosafety.html. 2013 Ref Type: Electronic Citation.
8. Porro D, Gasser B, Fossati T, Maurer M, Branduardi P, Sauer M, et al. Production of recombinant proteins and metabolites in yeasts: when are these systems better than bacterial production systems?. Appl Microbiol Biotechnol 2011, 89:939-948. 10.1007/s00253-010-3019-z, 21125266.
9. Corchero JL, Gasser B, Resina D, Smith W, Parrilli E, Vazquez F, et al. Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics. Biotechnol Adv 2013, 31:140-153. 10.1016/j.biotechadv.2012.09.001, 22985698.
10. Mustalahti E, Saloheimo M, Joensuu JJ. Intracellular protein production in Trichoderma reesei (Hypocrea jecorina) with hydrophobin fusion technology. N Biotechnol 2011, 30:262-268.
11. Idiris A, Tohda H, Kumagai H, Takegawa K. Engineering of protein secretion in yeast: strategies and impact on protein production. Appl Microbiol Biotechnol 2010, 86:403-417. 10.1007/s00253-010-2447-0, 20140428.
12. Decker EL, Reski R. Current achievements in the production of complex biopharmaceuticals with moss bioreactors. Bioprocess Biosyst Eng 2008, 31:3-9. 10.1007/s00449-007-0151-y, 17701058.
13. Gerngross TU. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Nat Biotechnol 2004, 22:1409-1414. 10.1038/nbt1028, 15529166.
14. Spolaore P, Joannis-Cassan C, Duran E, Isambert A. Commercial applications of microalgae. J Biosci Bioeng 2006, 101:87-96. 10.1263/jbb.101.87, 16569602.
15. Rme-Vega TC, Lim DK, Timmins M, Vernen F, Li Y, Schenk PM. Microalgal biofactories: a promising approach towards sustainable omega-3 fatty acid production. Microb Cell Fact 2012, 11:96. 10.1186/1475-2859-11-96, 3465194, 22830315.
16. Hempel F, Bozarth AS, Lindenkamp N, Klingl A, Zauner S, Linne U, et al. Microalgae as bioreactors for bioplastic production. Microb Cell Fact 2011, 10:81. 10.1186/1475-2859-10-81, 3214846, 22004563.
17. Specht E, Miyake-Stoner S, Mayfield S. Micro-algae come of age as a platform for recombinant protein production. Biotechnol Lett 2010, 32:1373-1383. 10.1007/s10529-010-0326-5, 2941057, 20556634.
18. Rhee SJ, Lee JE, Lee CH. Importance of lactic acid bacteria in Asian fermented foods. Microb Cell Fact 2011, 10(1):S5. 10.1186/1475-2859-10-5, 3231931, 21995342.
19. De Vos WM. Systems solutions by lactic acid bacteria: from paradigms to practice. Microb Cell Fact 2011, 10(1):S2. 10.1186/1475-2859-10-2, 3231926, 21995776.
20. Arendt EK, Moroni A, Zannini E. Medical nutrition therapy: use of sourdough lactic acid bacteria as a cell factory for delivering functional biomolecules and food ingredients in gluten free bread. Microb Cell Fact 2011, 10(1):S15. 10.1186/1475-2859-10-15, 3231922, 21995616.
21. Teusink B, Bachmann H, Molenaar D. Systems biology of lactic acid bacteria: a critical review. Microb Cell Fact 2011, 10(1):S11. 10.1186/1475-2859-10-11, 3231918, 21995498.
22. Garcia-Fruitos E. Lactic Acid Bacteria: a promising alternative for recombinant protein production. Microb Cell Fact 2012, 11:157. 10.1186/1475-2859-11-157, 3528458, 23234563.
23. Peterbauer C, Maischberger T, Haltrich D. Food-grade gene expression in lactic acid bacteria. Biotechnol J 2011, 6:1147-1161. 10.1002/biot.201100034, 21858927.
24. Morello E, Bermudez-Humaran LG, Llull D, Sole V, Miraglio N, Langella P, et al. Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion. J Mol Microbiol Biotechnol 2008, 14:48-58. 10.1159/000106082, 17957110.
25. Pontes DS, de Azevedo MS, Chatel JM, Langella P, Azevedo V, Miyoshi A. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems. Protein Expr Purif 2011, 79:165-175. 10.1016/j.pep.2011.06.005, 21704169.
26. Daniel C, Roussel Y, Kleerebezem M, Pot B. Recombinant lactic acid bacteria as mucosal biotherapeutic agents. Trends Biotechnol 2011, 29:499-508. 10.1016/j.tibtech.2011.05.002, 21665301.
27. Hu S, Kong J, Sun Z, Han L, Kong W, Yang P. Heterologous protein display on the cell surface of lactic acid bacteria mediated by the S-layer protein. Microb Cell Fact 2011, 10:86. 10.1186/1475-2859-10-86, 3215925, 22035337.
28. Bermudez-Humaran LG, Kharrat P, Chatel JM, Langella P. Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines. Microb Cell Fact 2011, 10(1):S4. 10.1186/1475-2859-10-4, 3231930, 21995317.
29. Scavone P, Miyoshi A, Rial A, Chabalgoity A, Langella P, Azevedo V, et al. Intranasal immunisation with recombinant lactococcus lactis displaying either anchored or secreted forms of proteus mirabilis MrpA fimbrial protein confers specific immune response and induces a significant reduction of kidney bacterial colonisation in mice. Microbes Infect 2007, 9:821-828. 10.1016/j.micinf.2007.02.023, 17540603.
30. Chen R. Bacterial expression systems for recombinant protein production: E. coli and beyond. Biotechnol Adv 2012, 30:1102-1107. 10.1016/j.biotechadv.2011.09.013, 21968145.
31. Terpe K. Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol 2003, 60:523-533.
32. Hahn HP, von Specht BU. Secretory delivery of recombinant proteins in attenuated salmonella strains: potential and limitations of type I protein transporters. FEMS Immunol Med Microbiol 2003, 37:87-98. 10.1016/S0928-8244(03)00092-0, 12832111.
33. Simon B, Nomellini J, Chiou P, Bingle W, Thornton J, Smit J, et al. Recombinant vaccines against infectious hematopoietic necrosis virus: production by the Caulobacter crescentus S-layer protein secretion system and evaluation in laboratory trials. Dis Aquat Organ 2001, 44:17-27.
34. Duncan G, Tarling CA, Bingle WH, Nomellini JF, Yamage M, Dorocicz IR, et al. Evaluation of a new system for developing particulate enzymes based on the surface (S)-layer protein (RsaA) of Caulobacter crescentus: fusion with the beta-1,4-glycanase (Cex) from the cellulolytic bacterium Cellulomonas fimi yields a robust, catalytically active product. Appl Biochem Biotechnol 2005, 127:95-110. 10.1385/ABAB:127:2:095, 16258187.
35. Laible PD, Scott HN, Henry L, Hanson DK. Towards higher-throughput membrane protein production for structural genomics initiatives. J Struct Funct Genomics 2004, 5:167-172.
36. Duilio A, Tutino ML, Marino G. Recombinant protein production in Antarctic Gram-negative bacteria. Methods Mol Biol 2004, 267:225-237.
37. Rippa V, Papa R, Giuliani M, Pezzella C, Parrilli E, Tutino ML, et al. Regulated recombinant protein production in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125. Methods Mol Biol 2012, 824:203-218. 10.1007/978-1-61779-433-9_10, 22160900.
38. Giuliani M, Parrilli E, Ferrer P, Baumann K, Marino C, Tutino ML. Process optimization for recombinant protein production in the psychrophilic bacterium Pseudoalteromonas haloplanktis. Process Biochem 2011, 46:953-959.
39. Vigentini I, Merico A, Tutino ML, Compagno C, Marino G. Optimization of recombinant human nerve growth factor production in the psychrophilic Pseudoalteromonas haloplanktis. J Biotechnol 2006, 127:141-150. 10.1016/j.jbiotec.2006.05.019, 16859797.
40. Miyake R, Kawamoto J, Wei YL, Kitagawa M, Kato I, Kurihara T, et al. Construction of a low-temperature protein expression system using a cold-adapted bacterium, Shewanella sp. strain Ac10, as the host. Appl Environ Microbiol 2007, 73:4849-4856. 10.1128/AEM.00824-07, 1951021, 17526788.
41. Retallack DM, Jin H, Chew L. Reliable protein production in a Pseudomonas fluorescens expression system. Protein Expr Purif 2011, 81:157-165.
42. Jin H, Cantin GT, Maki S, Chew LC, Resnick SM, Ngai J, et al. Soluble periplasmic production of human granulocyte colony-stimulating factor (G-CSF) in Pseudomonas fluorescens. Protein Expr Purif 2011, 78:69-77. 10.1016/j.pep.2011.03.002, 21396452.
43. Dammeyer T, Steinwand M, Kruger SC, Dubel S, Hust M, Timmis KN. Efficient production of soluble recombinant single chain Fv fragments by a Pseudomonas putida strain KT2440 cell factory. Microb Cell Fact 2011, 10:11. 10.1186/1475-2859-10-11, 3053225, 21338491.
44. Krzeslak J, Braun P, Voulhoux R, Cool RH, Quax WJ. Heterologous production of Escherichia coli penicillin G acylase in Pseudomonas aeruginosa. J Biotechnol 2009, 142:250-258. 10.1016/j.jbiotec.2009.05.005, 19481123.
45. Tokunaga H, Arakawa T, Tokunaga M. Novel soluble expression technologies derived from unique properties of halophilic proteins. Appl Microbiol Biotechnol 2010, 88:1223-1231. 10.1007/s00253-010-2832-8, 20838790.
46. Nagayoshi C, Tokunaga H, Hayashi A, Harazono H, Hamasaki K, Ando A, et al. Efficient expression of haloarchaeal nucleoside diphosphate kinase via strong porin promoter in moderately halophilic bacteria. Protein Pept Lett 2006, 13:611-615. 10.2174/092986606777145760, 16842117.
47. Anne J, Maldonado B, Van IJ, Van ML, Bernaerts K. Recombinant protein production and streptomycetes. J Biotechnol 2012, 158:159-167. 10.1016/j.jbiotec.2011.06.028, 21777629.
48. Liu L, Yang H, Shin HD, Li J, Du G, Chen J. Recent advances in recombinant protein expression by Corynebacterium, Brevibacterium, and Streptomyces: from transcription and translation regulation to secretion pathway selection. Appl Microbiol Biotechnol 2013, 97:9597-9608. 10.1007/s00253-013-5250-x, 24068337.
49. Ayala JC, Pimienta E, Rodriguez C, Anne J, Vallin C, Milanes MT, et al. Use of Strep-tag II for rapid detection and purification of Mycobacterium tuberculosis recombinant antigens secreted by Streptomyces lividans. J Microbiol Methods 2013, 94:192-198. 10.1016/j.mimet.2013.06.004, 23791917.
50. Chi WJ, Song JH, Oh EA, Park SW, Chang YK, Kim ES, et al. Medium optimization and application of an affinity column chromatography for streptomyces griseus trypsin production from the recombinant Streptomyces griseus. J Microbiol Biotechnol 2009, 19:1191-1196.
51. Chary VK, de la Fuente JL, Leitao AL, Liras P, Martin JF. Overexpression of the lat gene in Nocardia lactamdurans from strong heterologous promoters results in very high levels of lysine-6-aminotransferase and up to two-fold increase in cephamycin C production. Appl Microbiol Biotechnol 2000, 53:282-288. 10.1007/s002530050022, 10772467.
52. Connell ND. Expression systems for use in actinomycetes and related organisms. Curr Opin Biotechnol 2001, 12:446-449. 10.1016/S0958-1669(00)00243-3, 11604318.
53. Guo XQ, Wei YM, Yu B. Recombinant Mycobacterium smegmatis expressing Hsp65-hIL-2 fusion protein and its influence on lymphocyte function in mice. Asian Pac J Trop Med 2012, 5:347-351. 10.1016/S1995-7645(12)60056-X, 22546648.
54. Noens EE, Williams C, Anandhakrishnan M, Poulsen C, Ehebauer MT, Wilmanns M. Improved mycobacterial protein production using a Mycobacterium smegmatis groEL1DeltaC expression strain. BMC Biotechnol 2011, 11:27. 10.1186/1472-6750-11-27, 3076238, 21439037.
55. Srivastava P, Deb JK. Gene expression systems in corynebacteria. Protein Expr Purif 2005, 40:221-229. 10.1016/j.pep.2004.06.017, 15766862.
56. Kikuchi Y, Itaya H, Date M, Matsui K, Wu LF. Production of Chryseobacterium proteolyticum protein-glutaminase using the twin-arginine translocation pathway in Corynebacterium glutamicum. Appl Microbiol Biotechnol 2008, 78:67-74. 10.1007/s00253-007-1283-3, 18064454.
57. Itaya H, Kikuchi Y. Secretion of Streptomyces mobaraensis pro-transglutaminase by coryneform bacteria. Appl Microbiol Biotechnol 2008, 78:621-625. 10.1007/s00253-007-1340-y, 2266784, 18219481.
58. Paradis FW, Warren RA, Kilburn DG, Miller RC. The expression of Cellulomonas fimi cellulase genes in Brevibacterium lactofermentum. Gene 1987, 61:199-206. 10.1016/0378-1119(87)90114-4, 3443308.
59. van Dijl JM, Hecker M. Bacillus subtilis: from soil bacterium to super-secreting cell factory. Microb Cell Fact 2013, 12:3. 10.1186/1475-2859-12-3, 3564730, 23311580.
60. Terpe K. Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol 2006, 72:211-222. 10.1007/s00253-006-0465-8, 16791589.
61. Westers L, Westers H, Quax WJ. Bacillus subtilis as cell factory for pharmaceutical proteins: a biotechnological approach to optimize the host organism. Biochim Biophys Acta 2004, 1694:299-310. 10.1016/j.bbamcr.2004.02.011, 15546673.
62. Pohl S, Harwood CR. Heterologous protein secretion by bacillus species from the cradle to the grave. Adv Appl Microbiol 2010, 73:1-25.
63. Biedendieck R, Bunk B, Furch T, Franco-Lara E, Jahn M, Jahn D. Systems biology of recombinant protein production in bacillus megaterium. Adv Biochem Eng Biotechnol 2010, 120:133-161.
64. Schallmey M, Singh A, Ward OP. Developments in the use of Bacillus species for industrial production. Can J Microbiol 2004, 50:1-17. 10.1139/w03-076, 15052317.
65. Yang M, Zhang W, Ji S, Cao P, Chen Y, Zhao X. Generation of an artificial double promoter for protein expression in Bacillus subtilis through a promoter trap system. PLoS One 2013, 8:e56321. 10.1371/journal.pone.0056321, 3568030, 23409173.
66. Kajino T, Ohto C, Muramatsu M, Obata S, Udaka S, Yamada Y, et al. A protein disulfide isomerase gene fusion expression system that increases the extracellular productivity of Bacillus brevis. Appl Environ Microbiol 2000, 66:638-642. 10.1128/AEM.66.2.638-642.2000, 91874, 10653729.
67. Kajino T, Kato K, Miyazaki C, Asami O, Hirai M, Yamada Y, et al. Isolation of a protease-deficient mutant of Bacillus brevis and efficient secretion of a fungal protein disulfide isomerase by the mutant. J Biosci Bioeng 1999, 87:37-42. 10.1016/S1389-1723(99)80005-X, 16232422.
68. David F, Steinwand M, Hust M, Bohle K, Ross A, Dubel S, et al. Antibody production in Bacillus megaterium: strategies and physiological implications of scaling from micro titer plates to industrial bioreactors. Biotechnol J 2011, 6:1516-1531. 10.1002/biot.201000417, 21805641.
69. Toyokawa Y, Takahara H, Reungsang A, Fukuta M, Hachimine Y, Tachibana S, et al. Purification and characterization of a halotolerant serine proteinase from thermotolerant Bacillus licheniformis RKK-04 isolated from Thai fish sauce. Appl Microbiol Biotechnol 2010, 86:1867-1875. 10.1007/s00253-009-2434-5, 20107983.
70. Deb P, Talukdar SA, Mohsina K, Sarker PK, Sayem SA. Production and partial characterization of extracellular amylase enzyme from P-001. Springerplus 2013, 2:154. 10.1186/2193-1801-2-154, 3631119, 23626928.
71. Le LY, Azevedo V, Oliveira SC, Freitas DA, Miyoshi A, Bermudez-Humaran LG, et al. Protein secretion in Lactococcus lactis: an efficient way to increase the overall heterologous protein production. Microb Cell Fact 2005, 4:2. 10.1186/1475-2859-4-2, 545053, 15631634.
72. Innocentin S, Guimaraes V, Miyoshi A, Azevedo V, Langella P, Chatel JM, et al. Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells. Appl Environ Microbiol 2009, 75:4870-4878. 10.1128/AEM.00825-09, 2708419, 19482952.
73. Miyoshi A, Bermudez-Humaran LG, Ribeiro LA, Le LY, Oliveira SC, Langella P, et al. Heterologous expression of Brucella abortus GroEL heat-shock protein in Lactococcus lactis. Microb Cell Fact 2006, 5:14. 10.1186/1475-2859-5-14, 1444932, 16556312.
74. Nguyen TT, Nguyen HA, Arreola SL, Mlynek G, Djinovic-Carugo K, Mathiesen G, et al. Homodimeric beta-galactosidase from Lactobacillus delbrueckii subsp. bulgaricus DSM 20081: expression in Lactobacillus plantarum and biochemical characterization. J Agric Food Chem 2012, 60:1713-1721. 10.1021/jf203909e, 3284191, 22283494.
75. Zhao LL, Liu M, Ge JW, Qiao XY, Li YJ, Liu DQ. Expression of infectious pancreatic necrosis virus (IPNV) VP2-VP3 fusion protein in Lactobacillus casei and immunogenicity in rainbow trouts. Vaccine 2012, 30:1823-1829. 10.1016/j.vaccine.2011.12.132, 22234263.
76. Eom JE, Moon SK, Moon GS. Heterologous production of pediocin PA-1 in Lactobacillus reuteri. J Microbiol Biotechnol 2010, 20:1215-1218. 10.4014/jmb.1003.03026, 20798585.
77. Damelin LH, Mavri-Damelin D, Klaenhammer TR, Tiemessen CT. Plasmid transduction using bacteriophage Phi(adh) for expression of CC chemokines by Lactobacillus gasseri ADH. Appl Environ Microbiol 2010, 76:3878-3885. 10.1128/AEM.00139-10, 2893477, 20418431.
78. Chen GQ. New challenges and opportunities for industrial biotechnology. Microb Cell Fact 2012, 11:111. 10.1186/1475-2859-11-111, 3520750, 22905695.
79. Lee SY, Mattanovich D, Villaverde A. Systems metabolic engineering, industrial biotechnology and microbial cell factories. Microb Cell Fact 2012, 11:156. 10.1186/1475-2859-11-156, 3539922, 23232052.